Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ·Healthcare·Biotechnology
$0.58
-3.86%
Mkt Cap $7.72M
No analyst coverage available
We don't have analyst ratings or price target data for Citius Pharmaceuticals, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.